于 淼, 宋 琦, 杨燕绥, 妥宏武. 中医按病种分值医保付费政策效果分析——基于柳州市医保改革实践. 2023. biomedRxiv.202306.00002
中医按病种分值医保付费政策效果分析——基于柳州市医保改革实践
通讯作者: 妥宏武, tuohongwu@163.com
DOI:10.12201/bmr.202306.00002
Analysis of the Effect of Traditional Chinese Medicine Medical Insurance Payment by the Diagnosis-Intervention Packet: Based on the Medical Insurance Reform Practice in Liuzhou
Corresponding author: TUO Hongwu, tuohongwu@163.com
-
摘要:柳州市在国内率先形成了依据中医病种结算数据制定的中医病种医保支付标准。这对鼓励中医医疗机构积极采用中医疗法,促进中医药发展具有重要意义。基于柳州市全市医疗机构住院结算数据,本文对柳州市中医优势病种按病种分值付费的医保支付方式改革进行评估。评估结果显示,经过严格遴选的中医病种的服务可及性逐步提高;对于脊柱退行性改变病种,中医治疗组的成本管理总体优于西医治疗组,对于下呼吸道感染性疾病,中医治疗组的成本管理还有待进一步加强;中医治疗能够较好地控制药费支出和检查费用支出增长,其患者体验较好、医疗安全和质量有保障。本文还总结了柳州市中医病种支付方式改革经验,并提出了进一步完善中医病种分值医保支付改革的政策建议。
Abstract: Liuzhou is the first city in China to form the medical insurance payment standard for Traditional Chinese Medicine (TCM) diseases based on TCM disease settlement data. It is of great significance in encouraging TCM medical institutions to actively adopt the TCM method and promoting the development of TCM. Based on the inpatient settlement data of medical institutions in Liuzhou, the paper evaluates the reform of the medical insurance payment method of Liuzhou city for the TCM dominant diseases. The evaluation results showed that: (1)The accessibility of services for strictly selected TCM diseases gradually improved; (2)For degenerative spine changes disease, the cost management of the TCM group was generally better than that of the Western Medicine group, and for lower respiratory tract infectious disease, the cost management of the TCM group needed to be further strengthened; (3)TCM treatment was able to better control the growth of drug expenditures and examination expenses, and patients had a better experience and guaranteed medical safety and quality. Furthermore,This paper also summarized the experience of the TCM disease payment reform in Liuzhou and puts forward policy recommendations to further improve the TCM diagnosis-intervention packet of medical insurance payment reform.
Key words: traditional Chinese medicine medical insurance payment reform diagnosis-intervention packet; ;提交时间:2023-06-05
版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。 -
图表
-
朱彦, ZHENG Jie, 李晓瑛, 杨啸林, HE Yongqun. 基本形式化本体BFO及中文版介绍. 2020. doi: 10.12201/bmr.202007.00009
曹剑波, 刘亚清, 张美成, 牛浩然, 姜峰. 按病种分值付费(DIP)的实施效果评估-基于合成控制法的清远市实证. 2023. doi: 10.12201/bmr.202301.00007
许光建, 乔羽堃. 我国医疗服务价格调整与医保支付方式改革的联动机制研究. 2021. doi: 10.12201/bmr.202104.00018
张婧怡, 高广颖, 胡星宇, 邓茜, 张达, 田佳帅, 张礼亮. 基于META分析的肺结核患者按病种支付方式实施效果研究. 2022. doi: 10.12201/bmr.202112.00012
林坤河, 刘宵, 熊英贝, 姚轶凡, 项莉. DIP支付方式与紧密型医共体总额付费政策融合探索. 2023. doi: 10.12201/bmr.202305.00002
林坤河, 刘宵, 黄雨萌, 黄梅香, 钟正东, 李浩, 熊英贝, 周津, 项莉. 区域点数法总额预算下医疗机构“冲点”行为分析——以DIP支付方式为例. 2022. doi: 10.12201/bmr.202207.00022
邢怡青, 贺睿博, 李浩淼, 张亮. 县域医保支付与医疗服务结构适配关系与机理——基于云县典型案例的分析. 2023. doi: 10.12201/bmr.202306.00005
林坤河, 姚轶凡, 熊英贝, 项莉. DRG收付费一体化改革影响机制分析——以福建泉州和福建三明为例. 2023. doi: 10.12201/bmr.202311.00001
郝倩, 章平. DRG付费模式下医保监管系统设计与实现. 2021. doi: 10.12201/bmr.202108.00018
伍琳, 李梦颖. 医保支付激励与医生多任务执行偏差——新的解释框架和政策启示. 2022. doi: 10.12201/bmr.202112.00013
-
序号 提交日期 编号 操作 1 2023-02-17 bmr.202306.00002V1
下载 -
-
公开评论 匿名评论 仅发给作者
引用格式
访问统计
- 阅读量:453
- 下载量:1
- 评论数:0